Search - tctmd.com

Displaying 1 - 20 of 160

Sort: Relevancy | Date

News Daily News

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

Michael O'Riordan

February 06, 2026

News Conference News AHA 2025

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

Michael O'Riordan

November 11, 2025

News Opinion Editor's Corner AHA 2025

What’s Going to Be Hot at AHA 2025?

Michael O'Riordan

November 05, 2025

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Daily News

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

Caitlin E. Cox

October 08, 2025

News Daily News

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Michael O'Riordan

September 23, 2025

News Conference News ESC 2025

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

Michael O'Riordan

August 30, 2025

News Daily News

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Michael O'Riordan

July 14, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News EuroPCR 2025

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

Yael L. Maxwell

May 23, 2025

News Opinion CV Team Dispatch

May 2025 Dispatch for the CV Team

L.A. McKeown

May 20, 2025

News Conference News ACC 2025

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

Caitlin E. Cox

April 02, 2025

News Industry News

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

January 30, 2025

News Daily News

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Todd Neale

December 06, 2024

News Conference News TCT 2024

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Caitlin E. Cox

November 08, 2024

News Conference News TCT 2024

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

Michael O'Riordan

October 29, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News ESC 2024

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Michael O'Riordan

September 02, 2024

News Conference News ESC 2024

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

Michael O'Riordan

September 01, 2024

News Conference News ESC 2024

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Michael O'Riordan

August 30, 2024

Advertisement

In-Hospital STEMI Patients Face Reperfusion Delays and Worse Outcomes

CELEBRATE: Zalunfiban, a Novel Glycoprotein IIb/IIIa Inhibitor, Helps in STEMI

What’s Going to Be Hot at AHA 2025?

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Type 2 MI Diagnoses on the Rise, but Best Course of Action Unknown

CELEBRATE: Prehospital Platelet Inhibitor Zalunfiban Hits Mark in STEMI

Mixed Results for Beta-blockers in Post-MI Patients With Preserved EF

No Clarity on Colchicine: Two Meta-analyses Spark Debate on Drug’s Merits

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Short DAPT in High-Bleeding-Risk Patients Reduces Recurrent Events: MASTER DAPT

May 2025 Dispatch for the CV Team

Nurses Can Be Pivotal in Post-ACS Secondary Prevention: ALLEPRE

Genomadix Inc. Announces Health Canada License for Rapid Genetic Test to Aid Therapy Selection for Stroke and Cardiovascular Disease Patients

Questions Raised Anew About Aspirin for Secondary Prevention of ASCVD

Percutaneous Mechanical Aspiration Promising for Right-Heart Infective Endocarditis

Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows

What’s Going to Be Big at TCT 2024?

SENIOR-RITA Offers Rare Insights Into Best Care for Older NSTEMI Patients

Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events

ABYSS: Safety Signal Seen When Beta-blockers Stopped in Post-MI Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content